Opus Point Partners Management, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2019$217,000
-32.6%
5,0640.0%0.39%
-17.6%
Q2 2019$322,000
-8.3%
5,0640.0%0.48%0.0%
Q1 2019$351,000
+51.3%
5,064
-5.2%
0.48%
-6.8%
Q4 2018$232,000
-50.4%
5,339
-13.0%
0.51%
-54.3%
Q3 2018$468,000
-3.5%
6,134
-2.8%
1.12%
+6.2%
Q2 2018$485,000
+30.4%
6,311
-13.4%
1.05%
+44.1%
Q1 2018$372,000
-5.3%
7,291
-13.9%
0.73%
+114.7%
Q4 2017$393,000
-38.0%
8,472
-28.8%
0.34%
-40.2%
Q3 2017$634,000
+66.0%
11,899
+93.3%
0.57%
+62.6%
Q2 2017$382,000
-53.8%
6,157
-49.5%
0.35%
-43.0%
Q1 2017$827,000
+8.2%
12,201
+12.3%
0.61%
+0.8%
Q4 2016$764,000
+52.2%
10,864
+53.6%
0.61%
+116.0%
Q3 2016$502,000
+45.1%
7,0740.0%0.28%
-15.6%
Q2 2016$346,000
-59.5%
7,074
-47.6%
0.33%
-49.5%
Q1 2016$855,000
-7.3%
13,500
+50.0%
0.66%
-9.5%
Q2 2015$922,000
+23.8%
9,000
-25.0%
0.73%
+17.0%
Q1 2015$745,00012,0000.62%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
Abingworth LLP 38,100$2,928,0001.67%
Opaleye Management Inc. 80,000$6,149,0001.59%
HIGHLINE CAPITAL MANAGEMENT, L.P. 410,000$31,517,0001.06%
Opus Point Partners Management, LLC 6,311$485,0001.05%
SECTOR GAMMA AS 68,015$5,228,0000.87%
Capital Impact Advisors, LLC 27,074$2,061,0000.76%
FORTALEZA ASSET MANAGEMENT INC/ 1,130$87,0000.71%
CAPITAL INTERNATIONAL LTD /CA/ 46,957$3,610,0000.63%
Virtus ETF Advisers LLC 8,794$676,0000.60%
Rock Springs Capital Management LP 200,000$15,374,0000.59%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders